Stocks to watch today on January 18: HCL Tech, InterGlobe Aviation, SpiceJet, Vedanta, Wipro, DHFL, JBM Auto among others are the top stocks to watch out for in Monday's trading session

Dr. Reddy's and RDIF had partnered up in September 2020, so as to conduct clinical trials of the Sputnik V vaccine, as well as having the rights for distribution of its first 100 million doses in India.

The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research

India participated in the trials too. In a statement issued on Friday, ICMR concluded the same and said there were no benefits of remdesivir in any of the patients

The American company said the data appeared inconsistent, the findings were premature and that other studies had validated the drug's benefits

The WHO said that the Solidarity trial looked at the effects of these treatments on overall mortality, initiation of ventilation, and duration of hospital stay in hospitalised patients

Lilly had previously said it would make one million doses of its single antibody treatment available by the end of the year

Last month, Hetero became the first Indian drug company to launch Favipiravir in 800/200mg dosage for the treatment of mild-to-moderate symptomatic Covid-19 patients

The COVID-19 pandemic is estimated to push an additional 88 million to 115 million people into extreme poverty this year, with the total rising to as many as 150 million by 2021

Coronavirus treatment: With the 400 mg FabiFlu, patients could undergo a more relaxed dosage. The company said that reducing pill burden has been a demand from doctors and patients alike

Gilead's second-quarter sales fell nearly 10% from a year earlier to $5.1 billion, short of the average analyst estimate of $5.3 billion, according to Refinitiv

For months before studies like these, learning what helps or harms has been undermined by \"desperation science\" as doctors and patients tried therapies on their own or through a host of studies not strong enough to give clear answers

Glenmark has also started a post-marketing surveillance study on FabiFlu in 1,000 patients to assess its efficacy and safety

The UN agency said that the decision, taken on the recommendation of the trial's international steering committee, does not affect other studies where the drugs are used for non-hospitalised patients or as prophylaxis

On June 23, Patanjali Ayurveda had launched 'Coronil' and 'Swasari'. It had claimed that these two drugs could be used for treating COVID-19 and had successfully treated 100 per cent of the COVID-19 patients it was administered to in clinical trials

Stock Market LIVE Updates on July 3: Bajaj Auto, followed by Asian Paints, Bharti Airtel, HUL, Reliance Industries, HUL and Kotak Bank were among the top gainers in the Sensex pack. On the contrary, Tata Steel, HDFC, M&M and Bajaj Finance were among the laggards

Cipla share price rose up to 2.1% to Rs 648 against earlier close of Rs 634.70 on BSE

Company says Favipiravir is backed by strong clinical evidence showing encouraging results in patients with mild to moderate COVID-19; can offer a rapid reduction in viral load in four days and provide faster symptomatic and radiological improvement

While two such therapies have entered the human clinical trial phase, more are expected in the coming weeks

Lilly is also doing preclinical studies of a third antibody treatment for the illness caused by the new coronavirus that could enter human clinical trials in the coming weeks, Chief Scientific Officer Daniel Skovronsky said